ZYRTEC-D 12 HOUR OTC
Generic Name and Formulations:
Cetirizine HCl 5mg, pseudoephedrine HCl 120mg; ext-rel tabs.
McNeil Consumer Healthcare
Indications for ZYRTEC-D 12 HOUR:
Seasonal or perennial allergic rhinitis with nasal congestion.
Swallow whole. 1 tab twice daily. Hepatic or renal impairment (CrCl ≤31mL/min): 1 tab once daily.
Hydroxyzine sensitivity. Narrow-angle glaucoma. Urinary retention. Severe hypertension or coronary artery disease. During or within 14 days of MAOIs.
Hypertension. Diabetes. Ischemic heart disease. Increased intraocular pressure. Hyperthyroidism. GI or GU obstruction. Seizure disorders. Elderly. Pregnancy (Cat.C). Nursing mothers: not recommended.
Antihistamine + sympathomimetic.
See Contraindications. Pseudoephedrine: Antagonizes antihypertensives. Increased ectopic pacemaker activity with digitalis. Avoid other sympathomimetics, alcohol, other CNS depressants.
Insomnia, dry mouth, somnolence, dizziness; rarely: elevated liver enzymes.
Endocrinology Advisor Articles
- Cushing Syndrome Results in Poor Quality of Life Even After Remission
- DPP-4 Inhibitors and Incidence of Rheumatoid Arthritis in Type 2 Diabetes
- Cost-Benefit Analysis of Insulin Analogs in Type 2 Diabetes
- Nonfunctioning Adrenal Incidentaloma Associated With Metabolic Syndrome
- Low Predictive Power of Biomarkers for Estimated Glomerular Filtration Rate Decline
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Link Between Gestational Diabetes and Risk for CVD and Diabetes in Hispanic/Latina Population
- Clinical Characteristics Altering Risks and Benefits of Sulfonylureas and Thiazolidinedione Therapy in T2D
- 6 Factors Related to Inclusion in Health Care Workplace Identified
- Weight Gain After Quitting Smoking May Increase Risk for T2D